Filing Details
- Accession Number:
- 0001179110-15-009262
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-05 16:05:32
- Reporting Period:
- 2015-06-03
- Filing Date:
- 2015-06-05
- Accepted Time:
- 2015-06-05 16:05:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1625630 | H Kenneth Wilson | C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451 | Svp, Sales And Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-06-03 | 5,388 | $68.77 | 25,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual prices per share range from $68.53 to $68.95, inclusive. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
